Drug
FOLFIRINOX regimen
FOLFIRINOX regimen is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_1
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
NCT07312422
unknownnot_applicable
Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer
NCT05262452
unknownnot_applicable
Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
NCT01771146
Clinical Trials (3)
Showing 3 of 3 trials
NCT07312422Phase 1
LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study
NCT05262452Not Applicable
Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer
NCT01771146Not Applicable
Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3